Studies Debunk Antibiotics As Preventing Heart Ills
Posted on: Thursday, 21 April 2005, 21:00 CDT
Two major studies - one led by a Hub doctor - have dealt a major blow to researchers who had hoped taking antibiotics would thwart heart attacks.
Both findings, published in today's New England Journal of Medicine, conclude taking antibiotics regularly doesn't prevent heart disease.
"It really does close the door on this chapter of trying to prevent heart attacks with antibiotics," said Dr. Christopher Cannon of Brigham and Women's Hospital, whose two-year study tracked more than 4,000 patients.
Clinicians have found more than three-quarters of heart attack patients have been infected with a common respiratory germ called Chlamydia pneumoniae. Researchers had hoped - and prior studies had suggested - that antibiotics to treat the bacteria could reduce heart attacks.
Both studies found that while the germ may help trigger heart disease, once people have the condition, treating the bug with antibiotics doesn't prevent heart problems.
Cannon's study involved more than 4,000 patients recently hospitalized for heart problems. The patients were given either 10 days of antibiotics or fake pills every month for two years.
In the other study, about 4,000 people who had suffered a heart attack or clogged artery problems took either antibiotics or a placebo once a week for a year.
Source: Boston Herald
Related Articles
- Hospital Care for Heart Attack, Heart Failure Patients Varies Across Nation
- Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients
- First Patient Enrolled in RAPID MI-ICE Study Employing InnerCool's Endovascular Temperature Modulation Therapy for Heart Attack
- Statin Use Associated With Lower Risks of Death and Hospitalization for Heart Failure Patients
- Boston Scientific Launches Two Large-Scale Studies of Wireless Home Monitoring System for Heart Failure Patients
- Vanderbilt Enrolling Heart Failure Patients in New Pacing Device Study
- Data From Two Published Studies Show Short- and Long- Term Benefits of CHF Solutions' Aquapheresis(TM) Therapy in Treating Heart Failure Patients With Fluid Overload
- Role of Cholesterol Lowering Drugs in Heart Failure Patients Evaluated in Yale Medical Center's Heart Study
- Infections of Febrile Neutropenic Patients in Malignant Hematological Diseases (Second Study Period)
- Breast Cancer Prevention Study Spotlights Debate Over Drug Trials
User Comments (0)

RSS Feeds